Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Eli Lilly and Company ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.

The agreement means Ro has become the first alternative to Lilly's recently launched LillyDirect direct-to-consumer (DTC) platform that will be able to offer the lower-cost version of Zepbound ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

More Canadian employers are offering benefits that are not traditionally offered in most benefits programs, according to a ...